A new concept for treatment of sinonasal polyposis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 11, 2000, Pages 1091-1092

  Kutting, B ^a   Nieschalk, M ^a   Brehler, R ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antileukotrienes; Sinonasal polyposis; Therapy

Indexed keywords

METHYLPREDNISOLONE; MONTELUKAST;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; RHINORRHEA; TREATMENT OUTCOME;

ACETATES; ADRENAL CORTEX HORMONES; DRUG THERAPY, COMBINATION; HUMAN; LEUKOTRIENE ANTAGONISTS; NASAL POLYPS; PARANASAL SINUS DISEASES; QUINOLINES; RECURRENCE;

EID: 0033780497     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00822.x     Document Type: Article

References (5)

1. Nasal polyps: Medical or surgery managment?
2. Surgical versus medical management of nasal polyps
3. Results of oral steroid treatment in nasal polyposis
4. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multicenter, randomized, double-blind trial
5. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis